Clinical Trial Update: A Study of AK104 With Chemotherapy as First-line Treatment in Patients With Advanced Pancreatic Cancer [Phase 2]

View source ↗

Summary

Clinical trial update showing AK104 in combination with chemotherapy as first-line treatment for advanced pancreatic cancer in a Phase 2 study, currently recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• AK104 (PD-1/CTLA-4 bispecific antibody)

Snippet

Sponsor: Akeso | Conditions: Pancreatic Cancer | Phase 2 | Status: RECRUITING